论文部分内容阅读
当前对许多癌症,特别是晚期癌症,尚缺乏有效的治疗手段。大量的研究资料表明,生物反应调节剂—欧耐特(重组人白介素—Ⅱ)在肿瘤治疗中有良好的效应。为验证欧耐特的临床效果,解放军附属307医院自1995年9月—1997年4月对15例肿瘤病人进行了临床观察。现报告如下。
At present, there are still no effective treatments for many cancers, especially advanced cancers. A large number of research data show that the biological response modifier-Otron (recombinant human interleukin-II) has a good effect in the treatment of cancer. In order to verify the clinical efficacy of Euclid, the 307 Affiliated Hospital of the People’s Liberation Army conducted clinical observations on 15 patients with cancer from September 1995 to April 1997. The report is as follows.